Briacell TherapeuticsBCTX
13F holders, Q1 2026 (March 31)16holders +3
6new positions
3sold out
$4.19avg. 13F price*
At the end of Q1 2026, 16 institutions reported holding Briacell Therapeutics Corp. (BCTX) in their 13F filings, up 3 from Q4 2025. 6 opened new positions and 3 sold out. The largest holders were Cable Car Capital, LP ($908K), Sabby Management, LLC ($310K) and Iridian Asset Management LLC ($272K).
- Company
- Briacell Therapeutics Corp.
- CUSIP
- 107930307
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $1.6M |
| Exits | 3 | $29K |
All 13F filers, Q4 2025 → Q1 2026: 382,448 shares bought and 5,330 shares sold, net +377,118 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Cable Car Capital, LP | 0.39% | New | 216,821 | $908K |
| Sabby Management, LLC | 5.85% | New | 73,915 | $310K |
| Iridian Asset Management LLC | 0.11% | New | 65,000 | $272K |
| LuminArx Capital Management LP | 0.07% | New | 15,000 | $63K |
| UBS Group AG | 0.00% | Add +1708.9% | 11,541 | $48K |
| Morgan Stanley | 0.00% | Reduce -13.7% | 3,021 | $13K |
| National Bank of Canada | 0.00% | New | 802 | $3K |
| Federation des caisses Desjardins du Quebec | 0.00% | Reduce -62.2% | 455 | $2K |
| Allworth Financial LP | 0.00% | No change | 100 | $419 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 19 | $78 |
| Group One Trading LLC | 0.00% | Reduce -77.1% | 16 | $67 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 7 | $29 |
| HHM Wealth Advisors, LLC | 0.00% | No change | 6 | $26 |
| Wells Fargo & Company | 0.00% | No change | 1 | $4 |
| Royal Bank of Canada | 0.00% | No change | 100 | $0 |
| FNY Investment Advisers, LLC | 0.00% | No change | 10 | $0 |
"% of holder's portfolio" is BCTX's weight in each manager's 13F, not the share of Briacell Therapeutics Corp. the manager owns.